The Segal Cancer Centre is the only Canadian site toi participate in an international effort to match patients with personnalized medications by delving deeper into tumor biology, offering better options for treating advanced cancer
Montreal, April 29, 2019 – An international clinical trial, published in Nature Medicine, revealed that combining RNA and DNA profiling gives a far more precise indication of the active biological elements within a tumor, enabling clinicians to more accurately determine which targeted therapies could improve survival among patients with advanced cancer.
See attachment for more details.